カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の口腔乾燥症治療薬市場予測2023-2029：スプレー、内服液、口腔錠、マウスウォッシュ

【英語タイトル】Drugs for Xerostomia Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8496）・商品コード：MMG23LY8496
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：114
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の口腔乾燥症治療薬市場規模と予測を収録しています。・世界の口腔乾燥症治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の口腔乾燥症治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の口腔乾燥症治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「スプレー」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

口腔乾燥症治療薬のグローバル主要企業は、Concordia、 AMICI、 Aurobindo Pharma Ltd、 Impax Labs、 Lannett Co Inc、 Padagis Us、 Amneal Pharmaceuticals Pvt. Ltd.、 Bausch Health Companies Inc.、 GSK、 Jazz Pharmaceuticals plc、 Mission Pharmacal Company、 OraCoat、 Cumberland Pharmaceuticals, Inc.、 Fleet, C.B., Company、 Parnell Pharmaceuticals, Inc、 Clinigen、 Sun Pharmなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、口腔乾燥症治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の口腔乾燥症治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の口腔乾燥症治療薬市場：タイプ別市場シェア、2022年
・スプレー、内服液、口腔錠、マウスウォッシュ

世界の口腔乾燥症治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の口腔乾燥症治療薬市場：用途別市場シェア、2022年
・スーパーマーケット、病院、その他

世界の口腔乾燥症治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の口腔乾燥症治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における口腔乾燥症治療薬のグローバル売上、2018年-2023年
・主要企業における口腔乾燥症治療薬のグローバル売上シェア、2022年
・主要企業における口腔乾燥症治療薬のグローバル販売量、2018年-2023年
・主要企業における口腔乾燥症治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Concordia、 AMICI、 Aurobindo Pharma Ltd、 Impax Labs、 Lannett Co Inc、 Padagis Us、 Amneal Pharmaceuticals Pvt. Ltd.、 Bausch Health Companies Inc.、 GSK、 Jazz Pharmaceuticals plc、 Mission Pharmacal Company、 OraCoat、 Cumberland Pharmaceuticals, Inc.、 Fleet, C.B., Company、 Parnell Pharmaceuticals, Inc、 Clinigen、 Sun Pharm

*************************************************************

・調査・分析レポートの概要
口腔乾燥症治療薬市場の定義
市場セグメント
世界の口腔乾燥症治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の口腔乾燥症治療薬市場規模
世界の口腔乾燥症治療薬市場規模：2022年 VS 2029年
世界の口腔乾燥症治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの口腔乾燥症治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の口腔乾燥症治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：スプレー、内服液、口腔錠、マウスウォッシュ
口腔乾燥症治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：スーパーマーケット、病院、その他
口腔乾燥症治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別口腔乾燥症治療薬市場規模 2022年と2029年
地域別口腔乾燥症治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Concordia、 AMICI、 Aurobindo Pharma Ltd、 Impax Labs、 Lannett Co Inc、 Padagis Us、 Amneal Pharmaceuticals Pvt. Ltd.、 Bausch Health Companies Inc.、 GSK、 Jazz Pharmaceuticals plc、 Mission Pharmacal Company、 OraCoat、 Cumberland Pharmaceuticals, Inc.、 Fleet, C.B., Company、 Parnell Pharmaceuticals, Inc、 Clinigen、 Sun Pharm
...

Drugs for Xerostomia include prescription and over-the-counter mouthwashes, artificial saliva or humectants to moisturize the mouth, mouthwashes specially for dry mouth, especially those containing xylitol
This report aims to provide a comprehensive presentation of the global market for Drugs for Xerostomia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Xerostomia. This report contains market size and forecasts of Drugs for Xerostomia in global, including the following market information:
Global Drugs for Xerostomia Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Drugs for Xerostomia Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Drugs for Xerostomia companies in 2022 (%)
The global Drugs for Xerostomia market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Spray Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drugs for Xerostomia include Concordia, AMICI, Aurobindo Pharma Ltd, Impax Labs, Lannett Co Inc, Padagis Us, Amneal Pharmaceuticals Pvt. Ltd., Bausch Health Companies Inc. and GSK, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Xerostomia manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Xerostomia Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Drugs for Xerostomia Market Segment Percentages, by Type, 2022 (%)
Spray
Oral Liquid
Buccal Tablet
Mouth Wash
Global Drugs for Xerostomia Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Drugs for Xerostomia Market Segment Percentages, by Application, 2022 (%)
Supermarket
Hospital
Other
Global Drugs for Xerostomia Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Drugs for Xerostomia Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Xerostomia revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Drugs for Xerostomia revenues share in global market, 2022 (%)
Key companies Drugs for Xerostomia sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Drugs for Xerostomia sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Concordia
AMICI
Aurobindo Pharma Ltd
Impax Labs
Lannett Co Inc
Padagis Us
Amneal Pharmaceuticals Pvt. Ltd.
Bausch Health Companies Inc.
GSK
Jazz Pharmaceuticals plc
Mission Pharmacal Company
OraCoat
Cumberland Pharmaceuticals, Inc.
Fleet, C.B., Company
Parnell Pharmaceuticals, Inc
Clinigen
Sun Pharm
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs for Xerostomia, market overview.
Chapter 2: Global Drugs for Xerostomia market size in revenue and volume.
Chapter 3: Detailed analysis of Drugs for Xerostomia manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs for Xerostomia in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Drugs for Xerostomia capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Drugs for Xerostomia Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Xerostomia Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Xerostomia Overall Market Size
2.1 Global Drugs for Xerostomia Market Size: 2022 VS 2029
2.2 Global Drugs for Xerostomia Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Drugs for Xerostomia Sales: 2018-2029
3 Company Landscape
3.1 Top Drugs for Xerostomia Players in Global Market
3.2 Top Global Drugs for Xerostomia Companies Ranked by Revenue
3.3 Global Drugs for Xerostomia Revenue by Companies
3.4 Global Drugs for Xerostomia Sales by Companies
3.5 Global Drugs for Xerostomia Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Drugs for Xerostomia Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Drugs for Xerostomia Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drugs for Xerostomia Players in Global Market
3.8.1 List of Global Tier 1 Drugs for Xerostomia Companies
3.8.2 List of Global Tier 2 and Tier 3 Drugs for Xerostomia Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Drugs for Xerostomia Market Size Markets, 2022 & 2029
4.1.2 Spray
4.1.3 Oral Liquid
4.1.4 Buccal Tablet
4.1.5 Mouth Wash
4.2 By Type – Global Drugs for Xerostomia Revenue & Forecasts
4.2.1 By Type – Global Drugs for Xerostomia Revenue, 2018-2023
4.2.2 By Type – Global Drugs for Xerostomia Revenue, 2024-2029
4.2.3 By Type – Global Drugs for Xerostomia Revenue Market Share, 2018-2029
4.3 By Type – Global Drugs for Xerostomia Sales & Forecasts
4.3.1 By Type – Global Drugs for Xerostomia Sales, 2018-2023
4.3.2 By Type – Global Drugs for Xerostomia Sales, 2024-2029
4.3.3 By Type – Global Drugs for Xerostomia Sales Market Share, 2018-2029
4.4 By Type – Global Drugs for Xerostomia Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Drugs for Xerostomia Market Size, 2022 & 2029
5.1.2 Supermarket
5.1.3 Hospital
5.1.4 Other
5.2 By Application – Global Drugs for Xerostomia Revenue & Forecasts
5.2.1 By Application – Global Drugs for Xerostomia Revenue, 2018-2023
5.2.2 By Application – Global Drugs for Xerostomia Revenue, 2024-2029
5.2.3 By Application – Global Drugs for Xerostomia Revenue Market Share, 2018-2029
5.3 By Application – Global Drugs for Xerostomia Sales & Forecasts
5.3.1 By Application – Global Drugs for Xerostomia Sales, 2018-2023
5.3.2 By Application – Global Drugs for Xerostomia Sales, 2024-2029
5.3.3 By Application – Global Drugs for Xerostomia Sales Market Share, 2018-2029
5.4 By Application – Global Drugs for Xerostomia Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Drugs for Xerostomia Market Size, 2022 & 2029
6.2 By Region – Global Drugs for Xerostomia Revenue & Forecasts
6.2.1 By Region – Global Drugs for Xerostomia Revenue, 2018-2023
6.2.2 By Region – Global Drugs for Xerostomia Revenue, 2024-2029
6.2.3 By Region – Global Drugs for Xerostomia Revenue Market Share, 2018-2029
6.3 By Region – Global Drugs for Xerostomia Sales & Forecasts
6.3.1 By Region – Global Drugs for Xerostomia Sales, 2018-2023
6.3.2 By Region – Global Drugs for Xerostomia Sales, 2024-2029
6.3.3 By Region – Global Drugs for Xerostomia Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Drugs for Xerostomia Revenue, 2018-2029
6.4.2 By Country – North America Drugs for Xerostomia Sales, 2018-2029
6.4.3 US Drugs for Xerostomia Market Size, 2018-2029
6.4.4 Canada Drugs for Xerostomia Market Size, 2018-2029
6.4.5 Mexico Drugs for Xerostomia Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Drugs for Xerostomia Revenue, 2018-2029
6.5.2 By Country – Europe Drugs for Xerostomia Sales, 2018-2029
6.5.3 Germany Drugs for Xerostomia Market Size, 2018-2029
6.5.4 France Drugs for Xerostomia Market Size, 2018-2029
6.5.5 U.K. Drugs for Xerostomia Market Size, 2018-2029
6.5.6 Italy Drugs for Xerostomia Market Size, 2018-2029
6.5.7 Russia Drugs for Xerostomia Market Size, 2018-2029
6.5.8 Nordic Countries Drugs for Xerostomia Market Size, 2018-2029
6.5.9 Benelux Drugs for Xerostomia Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Drugs for Xerostomia Revenue, 2018-2029
6.6.2 By Region – Asia Drugs for Xerostomia Sales, 2018-2029
6.6.3 China Drugs for Xerostomia Market Size, 2018-2029
6.6.4 Japan Drugs for Xerostomia Market Size, 2018-2029
6.6.5 South Korea Drugs for Xerostomia Market Size, 2018-2029
6.6.6 Southeast Asia Drugs for Xerostomia Market Size, 2018-2029
6.6.7 India Drugs for Xerostomia Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Drugs for Xerostomia Revenue, 2018-2029
6.7.2 By Country – South America Drugs for Xerostomia Sales, 2018-2029
6.7.3 Brazil Drugs for Xerostomia Market Size, 2018-2029
6.7.4 Argentina Drugs for Xerostomia Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Drugs for Xerostomia Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Drugs for Xerostomia Sales, 2018-2029
6.8.3 Turkey Drugs for Xerostomia Market Size, 2018-2029
6.8.4 Israel Drugs for Xerostomia Market Size, 2018-2029
6.8.5 Saudi Arabia Drugs for Xerostomia Market Size, 2018-2029
6.8.6 UAE Drugs for Xerostomia Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Concordia
7.1.1 Concordia Company Summary
7.1.2 Concordia Business Overview
7.1.3 Concordia Drugs for Xerostomia Major Product Offerings
7.1.4 Concordia Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.1.5 Concordia Key News & Latest Developments
7.2 AMICI
7.2.1 AMICI Company Summary
7.2.2 AMICI Business Overview
7.2.3 AMICI Drugs for Xerostomia Major Product Offerings
7.2.4 AMICI Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.2.5 AMICI Key News & Latest Developments
7.3 Aurobindo Pharma Ltd
7.3.1 Aurobindo Pharma Ltd Company Summary
7.3.2 Aurobindo Pharma Ltd Business Overview
7.3.3 Aurobindo Pharma Ltd Drugs for Xerostomia Major Product Offerings
7.3.4 Aurobindo Pharma Ltd Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.3.5 Aurobindo Pharma Ltd Key News & Latest Developments
7.4 Impax Labs
7.4.1 Impax Labs Company Summary
7.4.2 Impax Labs Business Overview
7.4.3 Impax Labs Drugs for Xerostomia Major Product Offerings
7.4.4 Impax Labs Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.4.5 Impax Labs Key News & Latest Developments
7.5 Lannett Co Inc
7.5.1 Lannett Co Inc Company Summary
7.5.2 Lannett Co Inc Business Overview
7.5.3 Lannett Co Inc Drugs for Xerostomia Major Product Offerings
7.5.4 Lannett Co Inc Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.5.5 Lannett Co Inc Key News & Latest Developments
7.6 Padagis Us
7.6.1 Padagis Us Company Summary
7.6.2 Padagis Us Business Overview
7.6.3 Padagis Us Drugs for Xerostomia Major Product Offerings
7.6.4 Padagis Us Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.6.5 Padagis Us Key News & Latest Developments
7.7 Amneal Pharmaceuticals Pvt. Ltd.
7.7.1 Amneal Pharmaceuticals Pvt. Ltd. Company Summary
7.7.2 Amneal Pharmaceuticals Pvt. Ltd. Business Overview
7.7.3 Amneal Pharmaceuticals Pvt. Ltd. Drugs for Xerostomia Major Product Offerings
7.7.4 Amneal Pharmaceuticals Pvt. Ltd. Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.7.5 Amneal Pharmaceuticals Pvt. Ltd. Key News & Latest Developments
7.8 Bausch Health Companies Inc.
7.8.1 Bausch Health Companies Inc. Company Summary
7.8.2 Bausch Health Companies Inc. Business Overview
7.8.3 Bausch Health Companies Inc. Drugs for Xerostomia Major Product Offerings
7.8.4 Bausch Health Companies Inc. Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.8.5 Bausch Health Companies Inc. Key News & Latest Developments
7.9 GSK
7.9.1 GSK Company Summary
7.9.2 GSK Business Overview
7.9.3 GSK Drugs for Xerostomia Major Product Offerings
7.9.4 GSK Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.9.5 GSK Key News & Latest Developments
7.10 Jazz Pharmaceuticals plc
7.10.1 Jazz Pharmaceuticals plc Company Summary
7.10.2 Jazz Pharmaceuticals plc Business Overview
7.10.3 Jazz Pharmaceuticals plc Drugs for Xerostomia Major Product Offerings
7.10.4 Jazz Pharmaceuticals plc Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.10.5 Jazz Pharmaceuticals plc Key News & Latest Developments
7.11 Mission Pharmacal Company
7.11.1 Mission Pharmacal Company Company Summary
7.11.2 Mission Pharmacal Company Drugs for Xerostomia Business Overview
7.11.3 Mission Pharmacal Company Drugs for Xerostomia Major Product Offerings
7.11.4 Mission Pharmacal Company Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.11.5 Mission Pharmacal Company Key News & Latest Developments
7.12 OraCoat
7.12.1 OraCoat Company Summary
7.12.2 OraCoat Drugs for Xerostomia Business Overview
7.12.3 OraCoat Drugs for Xerostomia Major Product Offerings
7.12.4 OraCoat Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.12.5 OraCoat Key News & Latest Developments
7.13 Cumberland Pharmaceuticals, Inc.
7.13.1 Cumberland Pharmaceuticals, Inc. Company Summary
7.13.2 Cumberland Pharmaceuticals, Inc. Drugs for Xerostomia Business Overview
7.13.3 Cumberland Pharmaceuticals, Inc. Drugs for Xerostomia Major Product Offerings
7.13.4 Cumberland Pharmaceuticals, Inc. Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.13.5 Cumberland Pharmaceuticals, Inc. Key News & Latest Developments
7.14 Fleet, C.B., Company
7.14.1 Fleet, C.B., Company Company Summary
7.14.2 Fleet, C.B., Company Business Overview
7.14.3 Fleet, C.B., Company Drugs for Xerostomia Major Product Offerings
7.14.4 Fleet, C.B., Company Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.14.5 Fleet, C.B., Company Key News & Latest Developments
7.15 Parnell Pharmaceuticals, Inc
7.15.1 Parnell Pharmaceuticals, Inc Company Summary
7.15.2 Parnell Pharmaceuticals, Inc Business Overview
7.15.3 Parnell Pharmaceuticals, Inc Drugs for Xerostomia Major Product Offerings
7.15.4 Parnell Pharmaceuticals, Inc Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.15.5 Parnell Pharmaceuticals, Inc Key News & Latest Developments
7.16 Clinigen
7.16.1 Clinigen Company Summary
7.16.2 Clinigen Business Overview
7.16.3 Clinigen Drugs for Xerostomia Major Product Offerings
7.16.4 Clinigen Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.16.5 Clinigen Key News & Latest Developments
7.17 Sun Pharm
7.17.1 Sun Pharm Company Summary
7.17.2 Sun Pharm Business Overview
7.17.3 Sun Pharm Drugs for Xerostomia Major Product Offerings
7.17.4 Sun Pharm Drugs for Xerostomia Sales and Revenue in Global (2018-2023)
7.17.5 Sun Pharm Key News & Latest Developments
8 Global Drugs for Xerostomia Production Capacity, Analysis
8.1 Global Drugs for Xerostomia Production Capacity, 2018-2029
8.2 Drugs for Xerostomia Production Capacity of Key Manufacturers in Global Market
8.3 Global Drugs for Xerostomia Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Drugs for Xerostomia Supply Chain Analysis
10.1 Drugs for Xerostomia Industry Value Chain
10.2 Drugs for Xerostomia Upstream Market
10.3 Drugs for Xerostomia Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Drugs for Xerostomia Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Drugs for Xerostomia in Global Market
Table 2. Top Drugs for Xerostomia Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Drugs for Xerostomia Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Drugs for Xerostomia Revenue Share by Companies, 2018-2023
Table 5. Global Drugs for Xerostomia Sales by Companies, (K Units), 2018-2023
Table 6. Global Drugs for Xerostomia Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Drugs for Xerostomia Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Drugs for Xerostomia Product Type
Table 9. List of Global Tier 1 Drugs for Xerostomia Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Xerostomia Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Drugs for Xerostomia Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Drugs for Xerostomia Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Drugs for Xerostomia Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Drugs for Xerostomia Sales (K Units), 2018-2023
Table 15. By Type - Global Drugs for Xerostomia Sales (K Units), 2024-2029
Table 16. By Application – Global Drugs for Xerostomia Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Drugs for Xerostomia Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Drugs for Xerostomia Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Drugs for Xerostomia Sales (K Units), 2018-2023
Table 20. By Application - Global Drugs for Xerostomia Sales (K Units), 2024-2029
Table 21. By Region – Global Drugs for Xerostomia Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Drugs for Xerostomia Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Drugs for Xerostomia Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Drugs for Xerostomia Sales (K Units), 2018-2023
Table 25. By Region - Global Drugs for Xerostomia Sales (K Units), 2024-2029
Table 26. By Country - North America Drugs for Xerostomia Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Drugs for Xerostomia Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Drugs for Xerostomia Sales, (K Units), 2018-2023
Table 29. By Country - North America Drugs for Xerostomia Sales, (K Units), 2024-2029
Table 30. By Country - Europe Drugs for Xerostomia Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Drugs for Xerostomia Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Drugs for Xerostomia Sales, (K Units), 2018-2023
Table 33. By Country - Europe Drugs for Xerostomia Sales, (K Units), 2024-2029
Table 34. By Region - Asia Drugs for Xerostomia Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Drugs for Xerostomia Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Drugs for Xerostomia Sales, (K Units), 2018-2023
Table 37. By Region - Asia Drugs for Xerostomia Sales, (K Units), 2024-2029
Table 38. By Country - South America Drugs for Xerostomia Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Drugs for Xerostomia Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Drugs for Xerostomia Sales, (K Units), 2018-2023
Table 41. By Country - South America Drugs for Xerostomia Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Drugs for Xerostomia Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Drugs for Xerostomia Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Drugs for Xerostomia Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Drugs for Xerostomia Sales, (K Units), 2024-2029
Table 46. Concordia Company Summary
Table 47. Concordia Drugs for Xerostomia Product Offerings
Table 48. Concordia Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Concordia Key News & Latest Developments
Table 50. AMICI Company Summary
Table 51. AMICI Drugs for Xerostomia Product Offerings
Table 52. AMICI Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. AMICI Key News & Latest Developments
Table 54. Aurobindo Pharma Ltd Company Summary
Table 55. Aurobindo Pharma Ltd Drugs for Xerostomia Product Offerings
Table 56. Aurobindo Pharma Ltd Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Aurobindo Pharma Ltd Key News & Latest Developments
Table 58. Impax Labs Company Summary
Table 59. Impax Labs Drugs for Xerostomia Product Offerings
Table 60. Impax Labs Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Impax Labs Key News & Latest Developments
Table 62. Lannett Co Inc Company Summary
Table 63. Lannett Co Inc Drugs for Xerostomia Product Offerings
Table 64. Lannett Co Inc Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Lannett Co Inc Key News & Latest Developments
Table 66. Padagis Us Company Summary
Table 67. Padagis Us Drugs for Xerostomia Product Offerings
Table 68. Padagis Us Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Padagis Us Key News & Latest Developments
Table 70. Amneal Pharmaceuticals Pvt. Ltd. Company Summary
Table 71. Amneal Pharmaceuticals Pvt. Ltd. Drugs for Xerostomia Product Offerings
Table 72. Amneal Pharmaceuticals Pvt. Ltd. Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Amneal Pharmaceuticals Pvt. Ltd. Key News & Latest Developments
Table 74. Bausch Health Companies Inc. Company Summary
Table 75. Bausch Health Companies Inc. Drugs for Xerostomia Product Offerings
Table 76. Bausch Health Companies Inc. Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Bausch Health Companies Inc. Key News & Latest Developments
Table 78. GSK Company Summary
Table 79. GSK Drugs for Xerostomia Product Offerings
Table 80. GSK Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. GSK Key News & Latest Developments
Table 82. Jazz Pharmaceuticals plc Company Summary
Table 83. Jazz Pharmaceuticals plc Drugs for Xerostomia Product Offerings
Table 84. Jazz Pharmaceuticals plc Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Jazz Pharmaceuticals plc Key News & Latest Developments
Table 86. Mission Pharmacal Company Company Summary
Table 87. Mission Pharmacal Company Drugs for Xerostomia Product Offerings
Table 88. Mission Pharmacal Company Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Mission Pharmacal Company Key News & Latest Developments
Table 90. OraCoat Company Summary
Table 91. OraCoat Drugs for Xerostomia Product Offerings
Table 92. OraCoat Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. OraCoat Key News & Latest Developments
Table 94. Cumberland Pharmaceuticals, Inc. Company Summary
Table 95. Cumberland Pharmaceuticals, Inc. Drugs for Xerostomia Product Offerings
Table 96. Cumberland Pharmaceuticals, Inc. Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Cumberland Pharmaceuticals, Inc. Key News & Latest Developments
Table 98. Fleet, C.B., Company Company Summary
Table 99. Fleet, C.B., Company Drugs for Xerostomia Product Offerings
Table 100. Fleet, C.B., Company Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Fleet, C.B., Company Key News & Latest Developments
Table 102. Parnell Pharmaceuticals, Inc Company Summary
Table 103. Parnell Pharmaceuticals, Inc Drugs for Xerostomia Product Offerings
Table 104. Parnell Pharmaceuticals, Inc Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Parnell Pharmaceuticals, Inc Key News & Latest Developments
Table 106. Clinigen Company Summary
Table 107. Clinigen Drugs for Xerostomia Product Offerings
Table 108. Clinigen Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Clinigen Key News & Latest Developments
Table 110. Sun Pharm Company Summary
Table 111. Sun Pharm Drugs for Xerostomia Product Offerings
Table 112. Sun Pharm Drugs for Xerostomia Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Sun Pharm Key News & Latest Developments
Table 114. Drugs for Xerostomia Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 115. Global Drugs for Xerostomia Capacity Market Share of Key Manufacturers, 2021-2023
Table 116. Global Drugs for Xerostomia Production by Region, 2018-2023 (K Units)
Table 117. Global Drugs for Xerostomia Production by Region, 2024-2029 (K Units)
Table 118. Drugs for Xerostomia Market Opportunities & Trends in Global Market
Table 119. Drugs for Xerostomia Market Drivers in Global Market
Table 120. Drugs for Xerostomia Market Restraints in Global Market
Table 121. Drugs for Xerostomia Raw Materials
Table 122. Drugs for Xerostomia Raw Materials Suppliers in Global Market
Table 123. Typical Drugs for Xerostomia Downstream
Table 124. Drugs for Xerostomia Downstream Clients in Global Market
Table 125. Drugs for Xerostomia Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Drugs for Xerostomia Segment by Type in 2022
Figure 2. Drugs for Xerostomia Segment by Application in 2022
Figure 3. Global Drugs for Xerostomia Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drugs for Xerostomia Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Drugs for Xerostomia Revenue, 2018-2029 (US$, Mn)
Figure 7. Drugs for Xerostomia Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Drugs for Xerostomia Revenue in 2022
Figure 9. By Type - Global Drugs for Xerostomia Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Drugs for Xerostomia Revenue Market Share, 2018-2029
Figure 11. By Type - Global Drugs for Xerostomia Sales Market Share, 2018-2029
Figure 12. By Type - Global Drugs for Xerostomia Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Drugs for Xerostomia Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Drugs for Xerostomia Revenue Market Share, 2018-2029
Figure 15. By Application - Global Drugs for Xerostomia Sales Market Share, 2018-2029
Figure 16. By Application - Global Drugs for Xerostomia Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Drugs for Xerostomia Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Drugs for Xerostomia Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Drugs for Xerostomia Revenue Market Share, 2018-2029
Figure 20. By Region - Global Drugs for Xerostomia Sales Market Share, 2018-2029
Figure 21. By Country - North America Drugs for Xerostomia Revenue Market Share, 2018-2029
Figure 22. By Country - North America Drugs for Xerostomia Sales Market Share, 2018-2029
Figure 23. US Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Drugs for Xerostomia Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Drugs for Xerostomia Sales Market Share, 2018-2029
Figure 28. Germany Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 29. France Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Drugs for Xerostomia Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Drugs for Xerostomia Sales Market Share, 2018-2029
Figure 37. China Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 41. India Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Drugs for Xerostomia Revenue Market Share, 2018-2029
Figure 43. By Country - South America Drugs for Xerostomia Sales Market Share, 2018-2029
Figure 44. Brazil Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Drugs for Xerostomia Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Drugs for Xerostomia Sales Market Share, 2018-2029
Figure 48. Turkey Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Drugs for Xerostomia Revenue, (US$, Mn), 2018-2029
Figure 52. Global Drugs for Xerostomia Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Drugs for Xerostomia by Region, 2022 VS 2029
Figure 54. Drugs for Xerostomia Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の口腔乾燥症治療薬市場予測2023-2029：スプレー、内服液、口腔錠、マウスウォッシュ] (コード：MMG23LY8496)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の口腔乾燥症治療薬市場予測2023-2029：スプレー、内服液、口腔錠、マウスウォッシュ]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のインテリジェント消毒ステーション市場予測2023-2029：滴下、スプレー
  • 世界の第4級アンモニウム表面消毒剤市場予測2023-2029：液体、ワイプ、スプレー
  • 世界のスプリンクラー灌漑＆マイクロ灌漑市場予測2023-2029：スプレー、ローター、ドリッパー、マイクロスプリンクラー、インパクト、ガン
  • 世界のヒト白癬薬市場2022年：クリーム、スプレー、その他
  • 世界の局所ヒドロコルチゾン市場2022年：スプレー、軟膏、ジェル

    • ◆H&Iグローバルリサーチのお客様（例）◆